Comparison of L-Carnitine and L-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH Article

Acosta, Maria F, Muralidhran, Priya, Abrahamson, Michael D et al. (2020). Comparison of L-Carnitine and L-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH . PULMONARY PHARMACOLOGY & THERAPEUTICS, 65 10.1016/j.pupt.2021.101998

Open Access

cited authors

  • Acosta, Maria F; Muralidhran, Priya; Abrahamson, Michael D; Grijalva, Carissa L; Carver, Megan; Tang, Haiyang; Klinger, Christina; Fineman, Jeffrey R; Black, Stephen M; Mansour, Heidi M

sustainable development goals

authors

publication date

  • December 1, 2020

published in

keywords

  • ARTERIAL-HYPERTENSION
  • COPD
  • Crystallinity
  • DELIVERY
  • DISPERSION
  • DRY POWDER INHALERS
  • Drug development
  • Inhalation aerosol medicine
  • LINE
  • Life Sciences & Biomedicine
  • MITOCHONDRIAL DYSFUNCTION
  • Monocrotaline
  • OXIDATIVE STRESS
  • Pharmacology & Pharmacy
  • Pulmonary hypertension
  • Respiratory System
  • Respiratory drug delivery
  • Science & Technology
  • Targeted drug delivery

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD

volume

  • 65